N-heteroaryl substituted aniline derivatives as HCV-antivirals
The present invention discloses compounds of Formula (I): wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
05.07.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention discloses compounds of Formula (I): wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection. |
|---|---|
| AbstractList | The present invention discloses compounds of Formula (I): wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection. |
| Author | PLANCHER JEAN-MARC WEIKERT ROBERT JAMES |
| Author_xml | – fullname: PLANCHER JEAN-MARC – fullname: WEIKERT ROBERT JAMES |
| BookMark | eNrjYmDJy89L5WSw89PNSC1JLcpPLKrMUSguTSouySwpLUlNUUjMy8zJzEtVSEktyixLLMksSy1WSCxW8HAO003MA3IzixJzinkYWNOAVCovlOZmUHBzDXH20E0tyI9PLS5ITE7NSy2JDw22NLYwMjK0cDIyJkIJADwuMnY |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US9382218B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US9382218B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 15:57:23 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US9382218B23 |
| Notes | Application Number: US201414768881 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160705&DB=EPODOC&CC=US&NR=9382218B2 |
| ParticipantIDs | epo_espacenet_US9382218B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20160705 |
| PublicationDateYYYYMMDD | 2016-07-05 |
| PublicationDate_xml | – month: 07 year: 2016 text: 20160705 day: 05 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | HOFFMANN-LA ROCHE INC |
| RelatedCompanies_xml | – name: HOFFMANN-LA ROCHE INC |
| Score | 3.0381172 |
| Snippet | The present invention discloses compounds of Formula (I): wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | N-heteroaryl substituted aniline derivatives as HCV-antivirals |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160705&DB=EPODOC&locale=&CC=US&NR=9382218B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcChV1JtWxdYHe5DcFhOSzeMQhSQNRegD25TeSh5bDJSkNFHx751d0-pFb8suDLOzO6-dxwLcM1PnJldtamlsRQ3DUqmwiqnGs1h3WOIY8k13ODIHkfG8YIsW5LtaGNkn9EM2R0SOSpHfaymvNz-PWIHMrawekhynyqdw5gZK4x2LbmkqUwLP7U_GwdhXfN-NpsroxXV01ISa7aG0PkAr2pI-29wTRSmb3xolPIXDCQIr6jNo8aIDx_7u47UOHA2beDcOG9arzuFxRF9F6koZbz_XpEJ-_w7yZyQucmErkgwv07vs412RuCIDf06RbLnI4l1XF0DC_swfUERkud_0MpruUdYvoV2UBb8CgsZ9atkO1y0tM2JjhSewipnN7SxNVStNu9D9E0zvn7VrOBHUk3mo7Aba9faN36K2rZM7Sacv_t-FQg |
| link.rule.ids | 230,309,783,888,25577,76883 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT8Iw9IWgEW-KGvGzB7Nb45atbDtMEzaWqTCIfIQbGVsJS8ggbGr8977WgV701rTJy-tr31ffRwHuWFPnTa5a1NTYnBqGqVJhFVONJ5Fus5ltyDfdbtgMRsbzhE0qkG5rYWSf0A_ZHBE5KkZ-L6S8Xv88YnkytzK_n6U4tXr0h46nlN6x6JamMsVrOe1-z-u5ius6o4ESvjq2jppQs1oorffQwrakpzRuiaKU9W-N4h_Bfh-BZcUxVHhWh5q7_XitDgfdMt6Nw5L18hN4COlCpK6sos3nkuTI799B_oREWSpsRZLgZXqXfbxzEuUkcMcUyZaKLN5lfgrEbw_dgCIi092mp6PBDmX9DKrZKuPnQNC4j03L5rqpJUZkzPEE5hGzuJXEsWrGcQMaf4K5-GftFmrBsNuZdp7Cl0s4FJSUOansCqrF5o1fo-YtZjeSZl9maogy |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=N-heteroaryl+substituted+aniline+derivatives+as+HCV-antivirals&rft.inventor=PLANCHER+JEAN-MARC&rft.inventor=WEIKERT+ROBERT+JAMES&rft.date=2016-07-05&rft.externalDBID=B2&rft.externalDocID=US9382218B2 |